| Ms Kathleen Patricia Denesha, RN | |
|
500 E 6th St, Ocean City, NJ 08226-3826 | |
| (609) 399-1862 | |
| (609) 339-9157 |
| Full Name | Ms Kathleen Patricia Denesha |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 500 E 6th St, Ocean City, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235340316 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MB048583 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kathleen Patricia Denesha, RN 197 Blackman Rd, Eht, NJ 08234-7514 Ph: (609) 788-8822 | Ms Kathleen Patricia Denesha, RN 500 E 6th St, Ocean City, NJ 08226-3826 Ph: (609) 399-1862 |
News Archive
InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
Researchers from the University of Utah have identified a process by which the most common types of urinary tract infection-causing bacteria are able to trigger bladder cell shedding and disable immune responses. According to this new study, published in the Jan. 19, 2012, issue of Cell Host & Microbe, α-hemolysin, a toxin secreted by many strains of Escherichia coli (E. coli), may play an important, unexpected role during both the establishment and persistence of urinary tract infections.
Researchers from the Bonn University Hospital implanted pacemaker electrodes into the medial forebrain bundle in the brains of patients suffering from major depression with amazing results: In six out of seven patients, symptoms improved both considerably and rapidly.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs).
› Verified 5 days ago
Mr. Chandrakant I. Udani, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 5548 Asbury Ave., Ocean City, NJ 08226 Phone: 609-399-1519 Fax: 609-398-4712 |